These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26170308)

  • 21. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
    Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
    Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
    Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel nucleolin-binding peptide for Cancer Theranostics.
    Kim JH; Bae C; Kim MJ; Song IH; Ryu JH; Choi JH; Lee CJ; Nam JS; Kim JI
    Theranostics; 2020; 10(20):9153-9171. PubMed ID: 32802184
    [No Abstract]   [Full Text] [Related]  

  • 24. Recognition of nucleolin through interaction with RNA G-quadruplex.
    Santos T; Miranda A; Campello MPC; Paulo A; Salgado G; Cabrita EJ; Cruz C
    Biochem Pharmacol; 2021 Jul; 189():114208. PubMed ID: 32860827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and proteomic characterization of the major proteins of the nucleolin-binding ribonucleoprotein complexes.
    Yanagida M; Shimamoto A; Nishikawa K; Furuichi Y; Isobe T; Takahashi N
    Proteomics; 2001 Nov; 1(11):1390-404. PubMed ID: 11922599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
    Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
    Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms.
    Kolev MV; Ruseva MM; Morgan BP; Donev RM
    J Immunol; 2010 Jun; 184(11):6035-42. PubMed ID: 20421646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
    Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs.
    Sheetz T; Mills J; Tessari A; Pawlikowski M; Braddom AE; Posid T; Zynger DL; James C; Embrione V; Parbhoo K; Foray C; Coppola V; Croce CM; Palmieri D
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
    Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
    J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolin phosphorylation regulates PARN deadenylase activity during cellular stress response.
    Zhang X; Xiao S; Rameau RD; Devany E; Nadeem Z; Caglar E; Ng K; Kleiman FE; Saxena A
    RNA Biol; 2018 Feb; 15(2):251-260. PubMed ID: 29168431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selection and characterization of human scFv antibodies against hepatocellular carcinoma].
    Huang J; Xiao Y; Tong YQ; Guo FJ; Zhou GH; Li YH; Hu JY; Li GC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):256-9. PubMed ID: 18328187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
    Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of Rat Monoclonal Antibody for Human Nucleolin.
    Nishino Y; Homma T; Ihara KI; Fujii J; Tachibana T; Yokoyama C
    Monoclon Antib Immunodiagn Immunother; 2023 Aug; 42(4):145-149. PubMed ID: 37589992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
    Tohidkia MR; Asadi F; Barar J; Omidi Y
    BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity.
    Chen L; Liu YH; Li YH; Jiang Y; Xie PL; Zhou GH; Li GC
    Int Immunopharmacol; 2014 Jan; 18(1):20-6. PubMed ID: 24239629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Nucleolin and Associated Genes in Prostate Cancer.
    Firlej V; Soyeux P; Nourieh M; Huet E; Semprez F; Allory Y; Londono-Vallejo A; de la Taille A; Vacherot F; Destouches D
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of anti-proliferative and apoptotic effects by anti-IL-25 receptor single chain antibodies in breast cancer cells.
    Younesi V; Nejatollahi F
    Int Immunopharmacol; 2014 Dec; 23(2):624-32. PubMed ID: 25466271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review).
    Thongchot S; Aksonnam K; Thuwajit P; Yenchitsomanus PT; Thuwajit C
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.